Wildcat Petroleum

WCAT · Main Market · Energy · mcap £2.4m · 0.1p 3 open situations →

Delisting proposed – Proposed Cancellation of Main Market Listing-plans (20 Feb 26) · read

EV: –
EV / EBIT: –
Net cash: –
FCF yield: –
Revenue: –
Share price 1y: −24%
Insiders 12m: bought £3k
Next report: around 30 Mar

Beta Briefing, track record and signals & risks are not ready for Wildcat Petroleum yet.

We follow 960 UK small caps and every one of their announcements – often hundreds per company. 101 companies are already wired into a briefing: browse them.

Timeline · every situation

dots = announcements

2026 Pivot to African gold processing Main Market delisting to Aquis Fundraise before end March Trading suspension over results publication

Open · 3

Cash shell / net cash above market value

Pivot to African gold processing

Board strengthened; no project secured

The pivot to African gold processing was announced on 20 Feb 2026 and approved by shareholders on 31 Mar 2026, with no binding agreements. The 22 Oct 2026 newsletter adds Dr Madani Diallo (Executive Director) and James Knowles (Senior Independent NED) to the Board and sets out a screening, evaluation and procurement process. Sudan remains part of the focus. No project or funding is named.

Board additions: Dr Madani Diallo (Executive Director); James Knowles (Senior Independent Non-Executive Director) 22 Oct 2026 ↗
Approach: Source, evaluate and procure African gold projects, with an emphasis on gold processing 22 Oct 2026 ↗
Geography: Sudan remains part of the previously announced African focus 22 Oct 2026 ↗
Commitments: Any commitment subject to due diligence, approvals and funding; no project named 22 Oct 2026 ↗

Next: Source and evaluate projects; announcements as developments occur

22 Oct 2026 Board strengthened; no project secured
31 Mar 2026 Approved by shareholders; no binding agreements
20 Feb 2026 Review done; no binding agreements

Open the full view – chart and every step →

Delisting / take-private

Main Market delisting to Aquis

Delayed; admission now expected Q4 2026

Led to Fundraise before end March – Still unraised; tied to Aquis admission

Shareholders approved leaving the Main Market for Aquis in March 2026, and on 3 Aug 2026 a provisional timetable targeted admission on 1 September. The 22 Oct 2026 newsletter says the move has been delayed to Q4 2026. The company intends to begin the transfer process.

Previous target: Admission to Aquis targeted for 1 September 2026 (provisional timetable, 3 Aug 2026) 22 Oct 2026 ↗
New timing: Expected to complete in the fourth quarter of 2026 22 Oct 2026 ↗
Next milestone: Company intends to begin the transfer process; further announcements in due course 22 Oct 2026 ↗

Next: Begin transfer process; Aquis admission expected Q4 2026

22 Oct 2026 Delayed; admission now expected Q4 2026
3 Aug 2026 Provisional timetable set; admission targeted 1 September
18 Jun 2026 Admission still pending; governance changes tied to it
31 Mar 2026 Shareholders approved; Aquis admission pending

Open the full view – chart and every step →

Dilutive fundraise

Fundraise before end March

Still unraised; tied to Aquis admission

Follows from Main Market delisting to Aquis – Delayed; admission now expected Q4 2026

3 Aug 2026 Still unraised; tied to Aquis admission
18 Jun 2026 Still deferred; further raises expected
31 Mar 2026 Replaced by £30k Chairman loan; raise deferred
20 Feb 2026 Planned, no terms

Open the full view – chart and every step →

Closed · 1

Legal & regulatoryTrading suspension over results publication Resolved; listing restored 12 November 2025 · 3 Nov 2025 – 31 Mar 2026

Company filings. Not investment advice.